The biophysical foundations of photodynamic therapy

Endoscopy

Volumn 30, Issue 4, 1998, Pages 387-391

  Moan, J ^a   Peng, Q ^a   Sorensen, R ^a   Iani, V ^a   Nesland, J M ^a  

^a INSTITUTE OF CANCER RESEARCH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN; SINGLET OXYGEN;

ANIMAL MODEL; BIOPHYSICS; CANCER; CANCER THERAPY; DIAGNOSTIC ACCURACY; DRUG DISTRIBUTION; DRUG SELECTIVITY; DRUG UPTAKE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIGHT ABSORPTION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; OXYGEN CONSUMPTION; PHOTOCHEMOTHERAPY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; SPECTROFLUOROMETRY; TOPICAL DRUG ADMINISTRATION;

EID: 0031927096     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1001288     Document Type: Review

References (36)

1. Loh CS, MacRobert AJ, Bedwell J, et al. Oral versus intravenous administration of 5-aminolevulinic acid for photodynamic therapy. Br J Cancer 1993; 68: 41-51.
2. Moseng D, Volden G, Midelfart K, et al. Treatment of mouse carcinoma with intratumoral injection of hematoporphyrin derivative and red light. Photodermatology 1985; 2: 107-10.
3. Santoro O, Bandieramonte G, Melloni E, et al. Photodynamic therapy by topical meso-tetraphenylporphinesulfonate tetrasodium salt administration in superficial basal cell carcinoma. Cancer Res 1990; 50: 4501-3.
4. Peng Q, Warloe T, Berg K, et al. 5-Aminolevulinic acid-based photodynamic therapy: clinical research and future challenges. Cancer 1997; 79: 2282-308.
5. Kongshaug M. Minireview: distribution of tetrapyrrole photosensitizers among human plasma proteins. Int J Biochem 1992; 24: 1239-65.
6. Peng Q, Moan J, Farrants G, et al. Localization of potent photosensitizers in human tumor LOX by means of laser scanning microscopy. Cancer Lett 1991; 58: 17-27.
7. Peng Q, Moan J, Nesland JM. Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy. Ultrastruct Pathol 1996; 20: 109-29.
8. Peng Q, Nesland JM, Moan J, et al. Localization of fluorescent Photofrin II and aluminum phthalocyanine tetrasulfonate in transplanted human malignant tumor LOX and normal tissues of nude mice using highly light-sensitive video intensification microscopy. Int J Cancer 1990; 45: 927-9.
9. Peng Q, Moan J, Nesland JM, Rimington C. Aluminum phthalocyanines with asymmetrical lower sulfonation and with symmetrical higher sulfonation: a comparison of localizing and photosensitizing mechanism in human tumor xenografts. Int J Cancer 1990; 46: 719-26.
10. Peng Q, Moan J. Correlation of distribution of sulphonated aluminum phthalocyanines with their photodynamic effect in tumor and skin of mice bearing CaD2 mammary carcinoma. Br J Cancer 1995; 72: 565-74.
11. Peng Q, Moan J, Ma LW, Nesland JM. Uptake, localization and photodynamic effect of meso-tetra(hydroxypheny)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma. Cancer Res 1995; 55: 2620-6.
12. Eden M, Haines B, Kahler H. The pH of rat tumors measured in vivo. J Natl Cancer Inst 1955; 16: 541-56.
13. Gullino PM, Clark SH, Grantham FH. The interstitial fluid of solid tumors. Cancer Res 1964; 24: 780-97.
14. Thomas JP, Girotti AW. Glucose administration augments in vivo uptake and phototoxicity of the tumor-localizing fraction of hematoporphyrin derivative. Photochem Photobiol 1989; 49: 241-7.
15. Peng Q, Moan J, Cheng LS. The effect of glucose administration on the uptake of Photofrin II in a human tumor xenograft. 1991; 58: 29-35
16. Allison BA, Pritchard PH, Levy JG. Evidence for low lipoprotein receptor-mediated uptake of benzoporphyrin derivative. Br J Cancer 1994; 69: 833-9.
17. Peng Q, Berg K, Moan J, et al. 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol 1997; 65: 235-51.
18. Moan J, Berg K. The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem Photobiol 1991; 53: 549-53.
19. Berg K. Mechanisms of cell damage in photodynamic therapy. In: Hönigsman H, Jori G, Young AR, eds. The fundamental basis of phototherapy. Milan: OEMF, 1996: 181-207.
20. Moan J, Iani V, Ma LW. In vivo fluorescence of phthalocyanines during light exposure. J Photochem Photobiol B Biol 1998; 42: 100-3.
21. Moan J, Rimington C, Sommer J. Cellular uptake and photosensitizing properties of hematoporphyrin di-ethers with similar chromatographic properties as the tumor localizing fraction of hematoporphyrin derivative. Cancer Lett 1987; 34: 283-9.
22. Berg K, Steen HB, Winkelman JW, Moan J. Synergistic effects of photoactivated tetra(4-sulfonatophenyl)porphine and nocodazole on microtubule assembly, accumulation of cells in mitosis and cell survival. J Photochem Photobiol B Biol 1992; 13: 59-70.
23. Ma LW, Berg K, Danielsen HE, et al. Enhanced antitumor effect of photodynamic therapy by microtubule inhibitors. Cancer Lett 1996; 109: 129-39.
24. Kessel D, Luo Y. Mitochondrial photodamage and PDT-induced apoptosis. J Photochem Photobiol B Biol 1998; 42: 89-95.
25. Fingar VH. Vascular effects of photodynamic therapy. J Clin Laser Med Surg 1996; 14: 323-8.
26. Henderson BW. Probing the effects of photodynamic therapy through in vivo - in vitro methods. In: Kessel D, ed. Photodynamic therapy of neoplastic diseases, Vol 1. Boca Raton: CRC Press, 1990: 169-88.
27. Henderson BW, Bellnier DA. Tissue localization of photosensitizers and the mechanism of photodynamic tissue destruction. In: Bock G, Harnett S, eds. Photosensitizing compounds: their chemistry, biology and clinical use. Chichester: Wiley, 1989: 112-30. (Ciba Foundation Symposium, 146).
28. Canti G, Ricci L, Cantone V, et al. Hematoporphyrin derivative photoradiation therapy in murine solid tumors. Cancer Lett 1983; 21: 233-7.
29. Moan J, Sommer S. Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. Cancer Res 1985; 45: 1608-10.
30. Bremner JCM, Adams GE, Pearson JK, et al. Increasing the effect of photodynamic therapy on the RIF1 murine sarcoma, using the bioreductive drugs RSU1069 and RB6145. Br J Cancer 1992; 66: 1070-6.
31. Svaasand LO. Optical dosimetry for direct and interstitial photoradiation therapy of malignant tumor. In: Doiron DR, Gomer CJ, eds. Porphyrin localization and treatment of tumors. New York: Liss, 1984: 91-114.
32. Wilson BC, Jeeves WP, Lowe DM. In vivo and postmortem measurements of the attenuation spectra of light in mammalian tissues. Photochem Photobiol 1985; 42: 153-62.
33. Cheong WF, Prahl SA, Welch AJ. A review of the optical properties of biological tissues. IEEE J Quantum Elect 1990; 26: 2166-85.
34. Iani V, Moan J, Ma LW. Measurements of light penetration into human tissues in vivo. SPIE 1996; 2625: 378-83.
35. Peng Q, Warloe T, Moan J, et al. Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma. Photochem Photobiol 1995; 62: 906-13.
36. Moan J, Berg K, Iani V. Action spectra of dyes relevant for photodynamic therapy. In: Moser JG, ed. Quantitative data of 2nd and 3rd generation photosensitizers for photodynamic therapy. London: Harwood Academic Publishers, 1997 [in press].